Record Information |
---|
Version | 2.0 |
---|
Created at | 2005-11-16 15:48:42 UTC |
---|
Updated at | 2021-08-15 04:56:50 UTC |
---|
NP-MRD ID | NP0000061 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 3-Pyridylacetic acid |
---|
Description | 3-Pyridylacetic acid is a breakdown product of nicotine (and other tobacco alkaloids) and is part of the nicotine degradation pathway. It is formed from 4-(3-pyridyl)-butanoate. One alkaloid in particular, myosmine, appears to be a major source for 3-pyridylacetic acid. The alkaloid myosmine is present not only in tobacco products but also in various foods. Myosmine is easily nitrosated, yielding 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) and the esophageal tobacco carcinogen N'-nitrosonornicotine. The two major metabolites of myosmine metabolism have been identified as 3-pyridylacetic acid (20-26%) and 4-oxo-4-(3-pyridyl)butyric acid (50-60%) (PMID: 16079272 ). 3-Pyridylacetatic acid is an analog of nicotinic acid. (PMID 13898750 ). |
---|
Structure | InChI=1S/C7H7NO2/c9-7(10)4-6-2-1-3-8-5-6/h1-3,5H,4H2,(H,9,10) |
---|
Synonyms | Value | Source |
---|
3-Pyridylacetate | Generator | 2-(3-Pyridyl)acetate | HMDB | 2-(3-Pyridyl)acetic acid | HMDB | 2-(Pyridin-3-yl)acetate | HMDB | 2-(Pyridin-3-yl)acetic acid | HMDB | 3-Carboxymethylpyridine | HMDB | a-(3-Pyridyl)acetate | HMDB | a-(3-Pyridyl)acetic acid | HMDB | alpha-(3-Pyridyl)acetate | HMDB | alpha-(3-Pyridyl)acetic acid | HMDB | Coletin | HMDB | Lessterol | HMDB | Lioxone | HMDB | Minedil | HMDB | Piridil | HMDB | Piristerol | HMDB | Pyridin-3-ylacetate | HMDB | Pyridin-3-ylacetic acid | HMDB | Toneon | HMDB | 2-(3-Pyridine)acetic acid | HMDB | 3-Pyridineacetic acid | HMDB |
|
---|
Chemical Formula | C7H7NO2 |
---|
Average Mass | 137.1360 Da |
---|
Monoisotopic Mass | 137.04768 Da |
---|
IUPAC Name | 2-(pyridin-3-yl)acetic acid |
---|
Traditional Name | 3-pyridylacetic acid |
---|
CAS Registry Number | 501-81-5 |
---|
SMILES | OC(=O)CC1=CN=CC=C1 |
---|
InChI Identifier | InChI=1S/C7H7NO2/c9-7(10)4-6-2-1-3-8-5-6/h1-3,5H,4H2,(H,9,10) |
---|
InChI Key | WGNUNYPERJMVRM-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, simulated) | V.dorna83 | | | 2021-08-23 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, simulated) | v.dorna83@yahoo.com | Not Available | Not Available | 2021-07-21 | View Spectrum |
| Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyridines and derivatives. Pyridines and derivatives are compounds containing a pyridine ring, which is a six-member aromatic heterocycle which consists of one nitrogen atom and five carbon atoms. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyridines and derivatives |
---|
Sub Class | Not Available |
---|
Direct Parent | Pyridines and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Pyridine
- Heteroaromatic compound
- Azacycle
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | |
---|
Predicted Properties | |
---|
General References | - Zwickenpflug W, Tyroller S, Richter E: Metabolism of myosmine in Wistar rats. Drug Metab Dispos. 2005 Nov;33(11):1648-56. Epub 2005 Aug 3. [PubMed:16079272 ]
- GINOULHIAC E, TENCONI LT, CHIANCONE FM: 3-Pyridineacetic acid and nicotinic acid: blood levels, urinary elimination and excretion of nicotinic acid derivatives in man. Nature. 1962 Mar 10;193:948-9. [PubMed:13898750 ]
- Miyamoto Y, Banno Y, Yamashita T, Fujimoto T, Oi S, Moritoh Y, Asakawa T, Kataoka O, Yashiro H, Takeuchi K, Suzuki N, Ikedo K, Kosaka T, Tsubotani S, Tani A, Sasaki M, Funami M, Amano M, Yamamoto Y, Aertgeerts K, Yano J, Maezaki H: Discovery of a 3-pyridylacetic acid derivative (TAK-100) as a potent, selective and orally active dipeptidyl peptidase IV (DPP-4) inhibitor. J Med Chem. 2011 Feb 10;54(3):831-50. doi: 10.1021/jm101236h. Epub 2011 Jan 10. [PubMed:21218817 ]
- Liao X, Zhu J, Rubab M, Feng YL, Poon R: An analytical method for the measurement of acid metabolites of tryptophan-NAD pathway and related acids in urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Apr 15;878(13-14):1003-6. doi: 10.1016/j.jchromb.2010.02.017. Epub 2010 Feb 23. [PubMed:20299289 ]
|
---|